From detecting pneumonia on a chest X-ray to assessing whether a dark spot on the skin is benign or malignant, medical AI ...

Patient groups typically form around specific disease areas with an aim of advocating for improved treatments and therapies for patients who fall into those categories—and they’re feeling the ...

Patient organizations and charities are at risk of aligning their interests with their corporate funders even when this doesn't benefit their members, according to a new study led by the University of ...

Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On Capitol Hill, advocates ...

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, shares findings from a survey on colorectal cancer care inequities, and how to address these challenges. In the second part of this ...

When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot bring a ...

Polypills formulated to combine three or four antihypertensive medications may be effective treatment strategies for a variety of patient types, three new studies presented at the European Society of ...

Four years after the last update in the National List of Essential Medicines (NLEM), patient advocacy groups have called for ...

Despite falling business interest in environmental, social and governance (ESG) policies and outright opposition to such sustainability and ethics commitments in the U.S., company ESG practices still ...

Patient organisations and charities are at risk of aligning their interests with their corporate funders even when this doesn't benefit their members, according to a new study led by the University of ...